<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03485781</url>
  </required_header>
  <id_info>
    <org_study_id>302/2016</org_study_id>
    <nct_id>NCT03485781</nct_id>
  </id_info>
  <brief_title>Propofol-induced EEG Changes in Hypoxic Brain Injury</brief_title>
  <acronym>PROPEA3</acronym>
  <official_title>Assessment of Hypoxic Brain Injury by Analyzing Propofol-induced EEG Changes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Oulu University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      PROPEA3 is a prospective observational study investigating the recovery of propofol-induced
      EEG slow-wave activity and its association with neurological outcome after cardiac arrest.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROPEA3 is a prospective observational study investigating the recovery of propofol-induced
      EEG slow-wave activity and its association with neurological outcome after cardiac arrest.
      Comatose adult patients admitted to intensive care unit (ICU) after cardiac arrest are
      included. Patients with previous neurological disease expected to affect substantially EEG
      are excluded. The patients' relatives are asked for an informed written consent to
      participate. In the intensive care, the patients are sedated using continuous infusion of
      propofol while receiving temperature management/hypothermia treatment following the ICUs'
      common practice. EEG is recorded continuously from the admission to the ICU until 48 hours
      from the cardiac arrest. EEG slow-wave activity is determined offline by calculating the
      low-frequency (&lt;1 Hz) power from the signal. The neurological recovery of the patients is
      defined 6 months after cardiac arrest from patient documents and/or by phone call to the
      patient/relative using Cerebral Performance Category. After the follow-up period patient or
      the relative is also asked to fill a survey (SF-36) to estimate the health and quality of
      life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 12, 2017</start_date>
  <completion_date type="Anticipated">April 12, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 12, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>EEG slow-wave activity</measure>
    <time_frame>0-48 hours</time_frame>
    <description>EEG slow-wave activity defined by the low-frequency (&lt;1 Hz) signal power calculated continuously from the beginning of EEG measurement until 48 hours from cardiac arrest. The study investigates the association between the slow-wave activity and neurological outcome i.e. Cerebral Performance Category after 6 month follow-up period.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Hypoxic-Ischemic Encephalopathy</condition>
  <condition>Cardiac Arrest</condition>
  <eligibility>
    <study_pop>
      <textblock>
        All eligible patients admitted to intensive care in the study units.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Comatose patients admitted to intensive care after cardiac arrest

        Exclusion Criteria:

          -  Previous neurological disease expected to affect EEG substantially
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jukka Kortelainen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Oulu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jukka Kortelainen, MD, PhD</last_name>
    <phone>+358 50 4474909</phone>
    <email>jukka.kortelainen@oulu.fi</email>
  </overall_contact>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Helsinki</city>
        <zip>00029</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna Hästbacka, MD, PhD</last_name>
      <phone>+358 50 4286701</phone>
      <email>johanna.hastbacka@hus.fi</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Oulu University Hospital</name>
      <address>
        <city>Oulu</city>
        <zip>90220</zip>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jukka Kortelainen, MD, PhD</last_name>
      <phone>+358 50 4474909</phone>
      <email>jukka.kortelainen@oulu.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Kortelainen J, Väyrynen E, Huuskonen U, Laurila J, Koskenkari J, Backman JT, Alahuhta S, Seppänen T, Ala-Kokko T. Pilot Study of Propofol-induced Slow Waves as a Pharmacologic Test for Brain Dysfunction after Brain Injury. Anesthesiology. 2017 Jan;126(1):94-103.</citation>
    <PMID>27749312</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>March 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 2, 2018</study_first_posted>
  <last_update_submitted>March 26, 2018</last_update_submitted>
  <last_update_submitted_qc>March 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 2, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EEG</keyword>
  <keyword>Intensive Care</keyword>
  <keyword>Propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

